s6y
Company name or ticker
Search
Checkmate Pharmaceuticals, Inc.
3
BASH ALAN: Initial statement of beneficial ownership of securities
Filed
Wednesday, March 2, 2022
Period
Mar 1, 2022
Accession number
0000899243-22-008579
Documents
FORM 3 SUBMISSION
3
EX-24 DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header